Successful treatment of Pityriasis rubra pilaris with brodalumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful treatment of Pityriasis rubra pilaris with brodalumab

Published:2019-12-18 Issue:2 Volume:61 Page:
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Australas J Dermatol

Author:

De Rosa Alina¹,Gambardella Alessio¹,Licata Gaetano¹^ORCID,Alfano Roberto²,Argenziano Giuseppe¹

Affiliation:

1. Dermatology Unit Department of Mentals and Physical Health and Preventive medicine University of Campania Luigi Vanvitelli Naples Napoli Italy

2. Department of Anesthesiology, Surgery and Emergency University of Campania Luigi Vanvitelli Naples Italy

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajd.13215

Reference5 articles.

1. The clinical and histomorphological features of pityriasis rubra pilaris

2. A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists

3. Ustekinumab as an Alternative Treatment Option for Chronic Pityriasis Rubra Pilaris

4. Secukinumab emerges as a rapidly effective therapy for pityriasis rubra pilaris;Bonomo L;Cutis,2018

5. Successful treatment of type I pityriasis rubra pilaris with ixekizumab

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful treatment of pityriasis rubra pilaris with brodalumab after nonresponse to IL-17A inhibition: A role for the innate cytokine IL-17C;JAAD Case Reports;2024-06

2. Biologics for Treatment of Pityriasis Rubra Pilaris: A Literature Review;Journal of Cutaneous Medicine and Surgery;2024-03-28

3. Bimekizumab bei refraktärer Pityriasis rubra pilaris;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-01

4. Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options;American Journal of Clinical Dermatology;2023-12-30

5. Bimekizumab in refractory pityriasis rubra pilaris;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3